Scientists have discovered that losing a key protein in small cell lung cancer triggers inflammation that actually helps ...

The emergence of cancer drug resistance remains one of the most pressing problems in cancer care and there is a critical need to devise approaches to mitigate it. However, the molecular mechanisms ...

Scientists discovered that certain cancer cells use a low-level activation of a DNA-dismantling enzyme—normally seen in cell death—to survive treatment. Instead of dying, these “persister cells” ...

A newly published study reports that APC-deficient cancer cells may depend on a single metabolic enzyme for survival, revealing a potential strategy for selectively targeting tumours associated with ...

Long before his time at Colgate, Jeff Arigo ’26, a John A. Golden ’66 Fellow, was fascinated by medicine. Through on-campus ...

A lack of vitamin B2 makes tumour cells more susceptible to a unique form of cell death. This was discovered by researchers ...

KU Leuven Center for Cancer Biology, in collaboration with the Francis Crick Institute, has discovered how cancer cells can ...

Lung cancer used to have grim outcomes but earlier detection is improving those odds. A new combined procedure with diagnosis ...

The human body cannot produce vitamin B2—also known as riboflavin—itself; it must absorb the important substance through diet ...